Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolio

Watch on YouTube ↗  |  April 29, 2026 at 18:22  |  3:10  |  CNBC

No analysis available.

Up Next
9:06
US Signals No Letup of Naval Blockade in Bid to Squeeze Iran
Bloomberg Markets · Apr 29
34:15
Do Valuations Still Matter?
The Compound News · Apr 29
1:29:55
Big Tech Faces Make or Break Moment | Open Interest 4/29/2026
Bloomberg Markets · Apr 29
44:12
$150 Oil By Q3? This Could Break Markets Warns Economist | Bob Ryan
The David Lin Report · Apr 29
12:42
A make or break day for stocks: The committee's top strategies
CNBC · Apr 29